ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Initiative: Start With Mechanism, Then answer The Many Questions, Klauser Says to Advisors

November 29, 1996

NIH RPG Success Rate to Fall Further

June 7, 2013

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

Food & Water Inc. Launches ‘Cancer Prevention Campaign’

May 1, 1992

In Brief: Reauthorization Bill Could Go To House Floor Next Week; Packwood Blocks Action In Senate

July 8, 1983

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997